Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Bharat Parenterals Ltd made available the audio recording of its Q4 FY26 earnings conference call, which took place on May 19, 2026. Investors can access the recording to review the discussion on the company's operational and financial performance for the quarter and year ended March 31, 2026.
May 19 2026 17:24:54
Bharat Parenterals Ltd - 541096 - Corporate Action-Board approves Dividend
Bharat Parenterals board recommended a final dividend of ₹1.00 per equity share (10% on ₹10 face value) for FY26. Payout is within 30 days of AGM approval.
May 18 2026 17:19:00
Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Outcome Of Board Meeting
Bharat Parenterals announced FY26 cons. revenue increased 1.5% to ₹345.4 cr, while PAT loss narrowed by 37.5%. The board recommended a final dividend of ₹1.00 per share and re-appointed its cost and internal auditors.
May 18 2026 16:59:59
Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Bharat Parenterals has scheduled an earnings conference call on May 19, 2026, at 3:00 PM IST. The call will discuss the company's operational and financial performance for Q4 and the full fiscal year 2026.
May 12 2026 09:47:04
Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Approving Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend On Equity Shares.
Bharat Parenterals' Board of Directors will convene on May 18, 2026, to review and approve the audited financial results for Q4 & FY26. The board will also consider recommending a final dividend for the financial year.
May 09 2026 14:03:02
Read More